You are here

Research Projects

Genetic variants have been found to cause epilepsy as well as affect how people respond to treatment. Whole exome sequencing is a new method of...

The application of whole genome sequencing (WGS) in the clinical care of patients with epilepsy is increasingly viable as the cost of these assays...

Failure of modern ASMs to reduce the prevalence of drug-resistant epilepsy has been attributed to over-reliance on rodent models of acute seizures in...

Point-of-care (POC) testing is the testing at the site of patient care. It is done on patients conveniently and immediately allowing patients and...

Antiepileptic drug is the mainstay of treatment modality for epilepsy. People with epilepsy often require lifelong antiepileptic drug treatment....

The current standard of care for epilepsy is to commence treatment with a single antiseizure medication (ASM) and if it fails, try successive drug...

Seventy million people have epilepsy with 34–76 per 100,000 developing the condition every year. To formulate rational treatment plans, it is...

Older age is now the most common time to develop epilepsy in high income settings. This is thought to be due to age related neurobiological changes...

Mainstream anti-epileptic drugs (AEDs) that are used to treat epilepsy and some other conditions are associated with a range of cutaneous side...

Epilepsy is one of the most common serious chronic neurological disorders and is estimated to affect approximately 68 million people worldwide....

From networks of interconnected neurons emerge complex non-linear dynamics. These dynamics can be difficult to interpret and classify. Conventional...

The development of reliable, accurate, non-invasive methodologies for continuous, long-term seizure monitoring is a critical part of the precision...